A cancer-recognizable MRI contrast agents using pH-responsive polymeric micelle

被引:150
作者
Kim, Kyoung Sub [1 ]
Park, Wooram [1 ]
Hu, Jun [2 ]
Bae, You Han [2 ]
Na, Kun [1 ]
机构
[1] Catholic Univ Korea, Dept Biotechnol, Bucheon Si 420743, Gyeonggi Do, South Korea
[2] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84108 USA
关键词
Cancer diagnosis; Magnetic resonance imaging; Micelles; Imaging agents; pH-responsive materials; LIVER-CANCER; NANOPARTICLES; COPOLYMER; THERAPY; RELEASE; PROBE;
D O I
10.1016/j.biomaterials.2013.10.004
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
A cancer-recognizable MRI contrast agents (CR-CAs) has been developed using pH-responsive polymeric micelles. The CR-CAs with pH sensitivity were self-assembled based on well-defined amphiphilic block copolymers, consisting of methoxy poly(ethylene glycol)-b-poly(L-histidine) (PEG-p(L-His)) and methoxy poly(ethylene glycol)-b-poly(L-lactic acid)-diethylenetriaminopentaacetic acid dianhydride-gadolinium chelate (PEG-p(L-LA)-DTPA-Gd). The CR-CAs have a spherical shape with a uniform size of similar to 40 nm at physiological pH (pH 7.4). However, in acidic tumoral environment (pH 6.5), the CR-CAs were destabilized due to the protonation of the imidazole groups of p(L-His) blocks, causing them to break apart into positively charged water-soluble polymers. As a result, the CR-CAs exhibit highly effective T-1 MR contrast enhancement in the tumor region, which enabled the detection of small tumors of similar to 3 mm(3) in vivo at 1.5 T within a few minutes. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:337 / 343
页数:7
相关论文
共 39 条
[1]   Gd(III)-based contrast agents for MRI [J].
Aime, S ;
Botta, M ;
Terreno, E .
ADVANCES IN INORGANIC CHEMISTRY - INCLUDING BIOINORGANIC STUDIES, VOL 57: RELAXOMETRY OF WATER-METAL ION INTERACTIONS, 2005, 57 :173-237
[2]   Drug targeting and tumor heterogeneity [J].
Bae, You Han .
JOURNAL OF CONTROLLED RELEASE, 2009, 133 (01) :2-3
[3]   Relaxivity Enhancement in Macromolecular and Nanosized GdIII-Based MRI Contrast Agents [J].
Botta, Mauro ;
Tei, Lorenzo .
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2012, (12) :1945-1960
[4]   Nanoparticle and targeted systems for cancer therapy [J].
Brannon-Peppas, Lisa ;
Blanchette, James O. .
ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 :206-212
[5]  
Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]
[6]   Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications [J].
Caravan, P ;
Ellison, JJ ;
McMurry, TJ ;
Lauffer, RB .
CHEMICAL REVIEWS, 1999, 99 (09) :2293-2352
[7]   Strategies for increasing the sensitivity of gadolinium based MRI contrast agents [J].
Caravan, Peter .
CHEMICAL SOCIETY REVIEWS, 2006, 35 (06) :512-523
[8]   Gadolinium-Conjugated Dendrimer Nanoclusters as a Tumor-Targeted T1 Magnetic Resonance Imaging Contrast Agent [J].
Cheng, Zhiliang ;
Thorek, Daniel L. J. ;
Tsourkas, Andrew .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2010, 49 (02) :346-350
[9]   Hydrogels Incorporating GdDOTA: Towards Highly Efficient Dual T1/T2 MRI Contrast Agents [J].
Courant, Thomas ;
Roullin, Valerie Gaelle ;
Cadiou, Cyril ;
Callewaert, Maite ;
Andry, Marie Christine ;
Portefaix, Christophe ;
Hoeffel, Christine ;
de Goltstein, Marie Christine ;
Port, Marc ;
Laurent, Sophie ;
Vander Elst, Luce ;
Muller, Robert ;
Molinari, Michael ;
Chuburu, Francoise .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (36) :9119-9122
[10]   DNA-TiO2 nanoconjugates labeled with magnetic resonance contrast agents [J].
Endres, Paul J. ;
Paunesku, Tatjana ;
Vogt, Stefan ;
Meade, Thomas J. ;
Woloschak, Gayle E. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (51) :15760-+